FDA Warns CanaRx Over Drug Distribution ‘Scheme’ By Sam | February 28, 2019 The FDA hit Canadian drug distributor CanaRx with a warning letter, citing the company for supplying unapproved versions of FDA-cleared drugs. Source: Drug Industry Daily Posted in Drug Industry Daily